Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)

NCT04193202 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

419

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Cough

Interventions

DRUG: Gefapixant
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC